{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:30:05Z","timestamp":1764401405127},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1006\/mpat.2000.0363","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T19:46:30Z","timestamp":1032378390000},"page":"81-91","source":"Crossref","is-referenced-by-count":32,"title":["Pneumococcal pneumonia and bacteremia model in mice for the analysis of protective antibodies"],"prefix":"10.1006","volume":"29","author":[{"given":"Eirikur","family":"Saeland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gestur","family":"Vidarsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingileif","family":"Jonsdottir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/mpat.2000.0363_RF1","doi-asserted-by":"crossref","first-page":"759","DOI":"10.7326\/0003-4819-60-5-759","article-title":"Pneumococcal bacteremia with specific reference to bacteremic pneumococcal pneumonia","volume":"60","author":"Austrian","year":"1964","journal-title":"Ann Intern Med"},{"key":"10.1006\/mpat.2000.0363_RF2","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1001\/jama.1992.03490230058028","article-title":"Epidemiology of invasive childhood pneumococcal infections in Israel","volume":"268","author":"Dagan","year":"1992","journal-title":"JAMA"},{"key":"10.1006\/mpat.2000.0363_RF3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00006454-198507000-00001","article-title":"Preventing pneumococcal diseases in children: recommendations for using pneumococcal vaccine","volume":"4","author":"Giebink","year":"1985","journal-title":"Pediatr Infect Dis J"},{"key":"10.1006\/mpat.2000.0363_RF4","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1001\/jama.1993.03510150060030","article-title":"Pneumococcal polysaccharide vaccine efficacy","volume":"270","author":"Butler","year":"1993","journal-title":"JAMA"},{"key":"10.1006\/mpat.2000.0363_RF5","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1056\/NEJM199111213252101","article-title":"The protective efficacy of polyvalent pneumococcal polysaccharide vaccine","volume":"325","author":"Shapiro","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1006\/mpat.2000.0363_RF6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/infdis\/148.1.131","article-title":"Antibody response to pneumococcal vaccination in children younger than five years of age","volume":"148","author":"Douglas","year":"1983","journal-title":"J Infect Dis"},{"key":"10.1006\/mpat.2000.0363_RF7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408419409113544","article-title":"Pneumococcal infection and immunization in children","volume":"20","author":"Lee","year":"1994","journal-title":"Crit Rev Microbiol"},{"key":"10.1006\/mpat.2000.0363_RF8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0002-9343(87)90751-0","article-title":"Inefficacy of pneumococcal vaccine in a high risk population","volume":"83","author":"Forrester","year":"1987","journal-title":"Am J Med"},{"key":"10.1006\/mpat.2000.0363_RF9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00006454-199602000-00009","article-title":"Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants","volume":"15","author":"\u00c5hman","year":"1996","journal-title":"Pediatr Infect Dis"},{"key":"10.1006\/mpat.2000.0363_RF10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0022-3476(96)80130-2","article-title":"Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants","volume":"128","author":"Anderson","year":"1996","journal-title":"J Pediatr"},{"key":"10.1006\/mpat.2000.0363_RF11","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/00006454-199711000-00010","article-title":"Safety and immunogenicity of tetravalent pneumococcal vaccines containing 6B, 14, 19F and 23F polysaccharides conjugated to either tetanus toxoid or diphtheria toxoid in young infants and their boosterability by native polysaccharide antigens","volume":"16","author":"Dagan","year":"1997","journal-title":"Peadiatr Infect Dis J"},{"key":"10.1006\/mpat.2000.0363_RF12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1086\/514063","article-title":"Infant immunization with pneumococcal CRM197vaccines: Effect of saccharide size on immunogenicity and interactions with simultaneously administered vaccines","volume":"176","author":"Daum","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1006\/mpat.2000.0363_RF13","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00006454-199707000-00009","article-title":"Immune responses of infants vaccinated with serotype 6B pneumococcal polysaccharide conjugated with tetanus toxoid","volume":"16","author":"Sigurdardottir","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1006\/mpat.2000.0363_RF14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/infdis\/154.2.245","article-title":"Natural and vaccine related immunity to Streptococcus pneumoniae","volume":"154","author":"Musher","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1006\/mpat.2000.0363_RF15","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/BF02113425","article-title":"Pneumococcal virulence factors and host immune responses to them","volume":"14","author":"Watson","year":"1995","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1006\/mpat.2000.0363_RF16","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/infdis\/162.2.482","article-title":"IgG subclass response and opsonization of Streptococcus pneumoniae after vaccination of healthy adults","volume":"162","author":"Bardardottir","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1006\/mpat.2000.0363_RF17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1128\/CDLI.4.4.415-422.1997","article-title":"Standardization of an opsonophagocytic assay for the measurement of functional antibody activity againstStreptococcus pneumoniae using differentiated HL-60 cells","volume":"4","author":"Romero-Steiner","year":"1997","journal-title":"Clin Diagnost Lab Immunol"},{"key":"10.1006\/mpat.2000.0363_RF18","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/infdis\/170.3.592","article-title":"Opsonization and antibodies to capsular and cell wall polysaccharides of Streptococcus pneumoniae","volume":"170","author":"Vidarsson","year":"1994","journal-title":"J Infect Dis"},{"key":"10.1006\/mpat.2000.0363_RF19","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1128\/IAI.66.6.2866-2870.1998","article-title":"Isotypes and opsonophagocytosis of pneumococcus type 6B antibodies elicited in infants and adults by an experimental pneumococcus type 6B-tetanus toxoid vaccine","volume":"66","author":"Vidarsson","year":"1998","journal-title":"Infect Immun"},{"key":"10.1006\/mpat.2000.0363_RF20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0882-4010(95)90125-6","article-title":"Virulence of Streptococcus pneumoniae in mice: a standardized method for preparation and frozen storage of the experimental inoculum","volume":"18","author":"Aaberge","year":"1995","journal-title":"Microb Pathog"},{"key":"10.1006\/mpat.2000.0363_RF21","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/0264-410X(94)90151-1","article-title":"Adjuvant Quil A improves protection in mice and enhances opsonic capacity of antisera induced by pneumococcal polysaccharide conjugate vaccines","volume":"12","author":"AlonsoDeVelasco","year":"1994","journal-title":"Vaccine"},{"key":"10.1006\/mpat.2000.0363_RF22","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/infdis\/172.2.562","article-title":"Anti-polysaccharide immunoglobulin isotype levels and opsonic activity of antisera: Relationships with protection against Streptococcus pneumoniae infection in mice","volume":"172","author":"AlonsoDeVelasco","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1006\/mpat.2000.0363_RF23","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/0264-410X(94)90028-0","article-title":"Protection of infant mice from challenge with Streptococcus pneumoniae type 19F by immunization with a type 19F polysaccharide-pneumolysoid conjugate","volume":"12","author":"Lee","year":"1994","journal-title":"Vaccine"},{"key":"10.1006\/mpat.2000.0363_RF24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/infdis\/167.2.347","article-title":"Pneumococcal capsular polysaccharide-meningococcal outer membrane protein complex conjugate vaccines: Immunogenicity and efficacy in experimental pneumococcal otitis media","volume":"167","author":"Giebink","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1006\/mpat.2000.0363_RF25","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/infdis\/173.1.119","article-title":"Immunogenicity and efficacy of Streptococcus pneumoniae polysaccharide-protein conjugate vaccines against homologous and heterologous serotypes in the chinchilla otitis media model","volume":"173","author":"Giebink","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1006\/mpat.2000.0363_RF26","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1128\/IAI.58.12.3871-3876.1990","article-title":"Quantitative relationship between anticapsular antibody measured by enzyme linked immunosorbent assay or radioimmunoassay and protection of mice against challenge with Streptococcus pneumoniae serotype 4","volume":"58","author":"Musher","year":"1990","journal-title":"Infect Immun"},{"key":"10.1006\/mpat.2000.0363_RF27","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1056\/NEJM199505113321907","article-title":"Pathogenesis of pneumococcal infection","volume":"332","author":"Tuomanen","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1006\/mpat.2000.0363_RF28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/IAI.60.1.111-116.1992","article-title":"Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae","volume":"60","author":"Briles","year":"1992","journal-title":"Infect Immun"},{"key":"10.1006\/mpat.2000.0363_RF29","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1086\/515259","article-title":"Minimum protective serum concentrations of pneumococcal anti-capsular antibodies in infant rats","volume":"177","author":"Stack","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1006\/mpat.2000.0363_RF30","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1086\/513980","article-title":"Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae","volume":"175","author":"Wu","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1006\/mpat.2000.0363_RF31","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1086\/514093","article-title":"Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae","volume":"176","author":"Nahm","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1006\/mpat.2000.0363_RF32","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1128\/IAI.26.3.1116-1122.1979","article-title":"Comparative immunogenicity of group 6 pneumococcal type 6A (6) and type 6B (26) capsular polysaccharides","volume":"26","author":"Robbins","year":"1979","journal-title":"Infect Immun"},{"key":"10.1006\/mpat.2000.0363_RF33","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/infdis\/161.4.736","article-title":"Does naturally acquired IgG antibody to cell wall polysaccharide protect human subjects against pneumococcal infection?","volume":"161","author":"Musher","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1006\/mpat.2000.0363_RF34","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/mpat.1993.1029","article-title":"Antibodies against pneumococcal C-polysaccharide are not protective","volume":"14","author":"Nielsen","year":"1993","journal-title":"Microb Pathogen"},{"key":"10.1006\/mpat.2000.0363_RF35","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/0264-410X(96)82948-3","article-title":"PspA, a protection-eliciting pneumococcal protein: immunogenicity of isolated native PspA in mice","volume":"14","author":"Briles","year":"1996","journal-title":"Vaccine"},{"key":"10.1006\/mpat.2000.0363_RF36","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1128\/IAI.62.12.5683-5688.1994","article-title":"Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae","volume":"62","author":"Alexander","year":"1994","journal-title":"Infect Immun"},{"key":"10.1006\/mpat.2000.0363_RF37","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.4049\/jimmunol.154.7.3373","article-title":"A novel phospho\u00cdcholine antigen protects both normal and X-linked immune deficient mice against Streptococcus pneumoniae","volume":"154","author":"Fischer","year":"1995","journal-title":"J Immunol"},{"key":"10.1006\/mpat.2000.0363_RF38","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/infdis\/173.2.380","article-title":"Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice","volume":"173","author":"Tart","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1006\/mpat.2000.0363_RF39","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1128\/IAI.65.2.640-644.1997","article-title":"Oral immunization with pspA elicits protective humoral immunity against Streptococcus pneumoniae infection","volume":"65","author":"Yamamoto","year":"1997","journal-title":"Infect Immun"},{"key":"10.1006\/mpat.2000.0363_RF40","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4049\/jimmunol.150.2.543","article-title":"Repertoire diversity of antibody response to bacterial antigens in aged mice","volume":"150","author":"Nicoletti","year":"1993","journal-title":"J Immunol"},{"key":"10.1006\/mpat.2000.0363_RF41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1099\/00222615-45-5-319","article-title":"Establishment of a model of penicillin-resistant Streptococcus pneumoniae pneumonia in healthy CBA\/J mice","volume":"45","author":"Takashima","year":"1996","journal-title":"J Med Microbiol"},{"key":"10.1006\/mpat.2000.0363_RF42","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1128\/IAI.62.6.2582-2589.1994","article-title":"Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization","volume":"62","author":"Weiser","year":"1994","journal-title":"Infect Immun"},{"key":"10.1006\/mpat.2000.0363_RF43","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1128\/JCM.26.4.755-759.1988","article-title":"Prevention of pneumococcal otitis media in chinchillas with human bacterial polysaccharide immune globulin","volume":"26","author":"Shurin","year":"1988","journal-title":"J Clin Microbiol"},{"key":"10.1006\/mpat.2000.0363_RF44","doi-asserted-by":"crossref","first-page":"S204","DOI":"10.1093\/clind\/21.Supplement_3.S204","article-title":"The molecular basis of pneumococcal infection: A hypothesis","volume":"21 (Suppl. 3)","author":"Cundell","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1006\/mpat.2000.0363_RF45","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/infdis\/171.6.1387","article-title":"Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum","volume":"171","author":"Robbins","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1006\/mpat.2000.0363_RF46","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1172\/JCI6310","article-title":"Killing of Streptococcus pneumoniae by capsular polysaccharide-specific polymeric IgA, complement, and phagocytes","volume":"104","author":"Janoff","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1006\/mpat.2000.0363_RF47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1086\/314845","article-title":"Correlation of opsonophagocytosis and passive protection assays using human anti-capsular antibodies in an infant mouse model of bacteremia for Streptococcus pneumoniae","volume":"180","author":"Johnson","year":"1999","journal-title":"J Infect Dis"}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401000903632?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401000903632?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T23:24:03Z","timestamp":1680564243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401000903632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["S0882401000903632"],"URL":"https:\/\/doi.org\/10.1006\/mpat.2000.0363","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}